Orphan drug designation is a special status granted by regulatory authorities to encourage the development of medications for rare diseases or conditions affecting a small number of patients. This designation provides various benefits, including tax incentives, reduced fees, and a period of market exclusivity, which makes it easier for companies to invest in and bring these drugs to market despite the limited potential for profitability.
congrats on reading the definition of Orphan drug designation. now let's actually learn it.